Swiss Pharma Co. Seeks OK On Cystic Fibrosis Drug Award
A Swiss pharmaceuticals company is asking a Virginia federal court not only to confirm a $2.7 million arbitral award against a Japanese company following a dispute over a cystic fibrosis drug...To view the full article, register now.
Already a subscriber? Click here to view full article